Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
159studies shown
Showing 109-120 of 159
Behavioral study icon
TerminatedNCT01121536

Safety and Efficacy of Armodafinil Treatment for depression

This study was terminated in the United States, in Australia, in France, .... It is testing safety and Efficacy of Armodafinil Treatment for depression.

In France
Bipolarity, DepressionOtherFrom 18 Years to 65 Years
Countries
United States, Australia, France, ...
Sponsor
Cephalon
Condition
Bipolarity, Depression
Behavioral study icon
CompletedNCT04570202

Health cAre woRkers exposeD to COVID-19

This study is completed. It focuses on PTSD and currently lists study information in France.

In France
PTSD, DepressionBehavioralOver 18 Years
Countries
France
Sponsor
University Hospital, Tours
Condition
PTSD, Depression
Behavioral study icon
UnknownNCT05894980

How to Reduce Suicide prevention and Impulsivity in Depression

This study has public registry information. It focuses on depression and currently lists study information in France.

In France
Depression, SuicidalityBehavioralOver 18 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Besancon
Condition
Depression, Suicidality
Other study type icon
CompletedNCT04595123

Impact of COVID-19 Pandemic in Perinatal Mental Health (RISEUP-PPD-COVID-19)

This study is completed. It focuses on PTSD and currently lists study information in Albania, Brazil, Bulgaria, Chile, Cyprus, France, Greece, Israel, Malta, Portugal, Spain, Turkey, and the United Kingdom.

In France
PTSD, Depression, ...OtherOver 18 Years
Countries
France, United Kingdom, Albania, ...
Sponsor
University of Minho
Condition
PTSD, Depression, ...
Other study type icon
CompletedEUCTR 2008-005353-38

Vortioxetine for depression

This study is completed in France, in the United Kingdom, in Latvia, .... It is testing vortioxetine for depression.

In France
DepressionOther
Countries
France, United Kingdom, Latvia, ...
Sponsor
H. Lundbeck A/S
Condition
Depression
Drug study icon
CompletedNCT00868959

Lurasidone - A 24-week Extension Study of people with Bipolar I Depression

This study is completed. It focuses on bipolarity and currently lists study information in Canada, Colombia, Czech Republic, France, India, Japan, Lithuania, Peru, Poland, Romania, Russian Federation, Slovakia, South Africa, Ukraine, and the United States.

In France
Bipolarity, DepressionOtherFrom 18 Years to 75 Years
Countries
United States, France, Canada, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.